ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

PD-L1-Mediated Immunosuppression in Hepatocellular Carcinoma: Relationship with Macrophages Infiltration and Inflammatory Response Activity

Guo, Shuang; Wang, Xinyue; Zhou, Hanxiao; Gao, Yue; Wang, Peng; Zhi, Hui; Sun, Yue; Zhang, Yakun; Gan, Jing; Xiao, Yun*; Ning, Shangwei*哈尔滨医科大学; y
Biomolecules2022-9DOI: 10.3390/biom12091226
4被引5阅读
引用收藏
分享

摘要

Immune dysfunction and pro-oncogenic inflammation play critical roles in malignant progression and non-response to immunotherapy for hepatocellular carcinoma (HCC). In particular, PD-1/PD-L1 blockade therapy could induce durable tumor remissions and improve the prognosis of patients to a certain extent. However, PD-L1, as a promising biomarker, has limited knowledge about its relevance to tumor microenvironment (TME) characterization and endogenous inflammatory immune responses. In this study, we systematically investigated and characterized the important intercommunication of PD-L1 with immunosuppressive TME and inflammatory response activity in HCC and predicted promising therapeutic drugs to improve the current therapeutic strategy for specific patients. We identified aberrant expression patterns of PD-L1 in HCC and completely different clinical and molecular characteristics among the PD-L1 subgroups. PD-L1 positively associated with immunosuppressive macrophages and macrophage-derived cytokines, which may contribute to the polarization of macrophages. Moreover, inflammatory response activity exhibited significant differences between high and low PD-L1 expression groups and had robust positive correlativity of the infiltration level of tumor-associated macrophages. Notably, given the immunosuppressive and inflammatory microenvironment in HCC, we screened four candidate drugs, including dasatinib, vemurafenib, topotecan and AZD6482, and corroborated in two pharmacogenomics databases, which might have potential therapeutic implications in specific HCC patients. Our results enhanced the understanding of linkage in PD-L1 expression patterns with macrophages and inflammation, which may provide new insight into the pathogenic mechanisms and potential therapeutic strategy for HCC.

学科与关键词

关键词
PD-L1tumor-associated macrophagesimmunosuppressive tumor microenvironmentinflammatory responseimmunotherapy
相关
加载中…
  • Programmed cell death-ligand 1 expression in hepatocellular carcinoma and its correlation with clinicopathological characteristics
    Mou, Haibo; Yang, Qiu-an; Yu, Lanfang; Wang, Ting; Liu, Kui; Shen, Rong; Pan, Xuedong; Dai, Yi; Wan, Qing; Zhou, Fangling; Qian, Lili; Chen, Donglin; Yau, Thomas; Dong, Xiaowei; Wang, Xuemei*; Wang, Shuang*Journal of Gastroenterology and Hepatology, 2021, 36(9): 2601-2609.被引 3
  • Cancer-associated fibroblasts contribute to the immunosuppressive landscape and influence the efficacy of the combination therapy of PD-1 inhibitors and antiangiogenic agents in hepatocellular carcinoma
    Chen, Qiurui; Wang, Xuejia; Zheng, Yichen; Ye, Ting; Liu, Jing; Wang, Jin-Quan; Zhang, Wen-feng; Wu, Feng-Lin; Bo, Huaben; Shao, Hongwei; Zhang, Rongxin*; Shen, Han*Cancer, 2023, 129(21): 3405-3416.被引 1
  • CPI-203 improves the efficacy of anti-PD-1 therapy by inhibiting the induced PD-L1 overexpression in liver cancer
    Niu, Xiaoge; Wang, Wei; Liang, Taizhen; Li, Shasha; Yang, Chan; Xu, Xinfeng; Li, Lin*; Liu, Shuwen*Cancer Science, 2022, 113(1): 28-40.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Biomolecules
发表日期
2022-09
卷期
第 12 卷, 第 9 期
页码
1226
DOI
10.3390/biom12091226
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [32070672]; University Nursing Program for Young Scholars with Creative Talents in Heilongjiang Province [UNPYSCT-2020173]

作者

  • G

    Guo, Shuang (第一作者)

    harbin med univ

  • W

    Wang, Xinyue

    harbin med univ

查看全部 11 位作者收起作者
  • Z

    Zhou, Hanxiao

    harbin med univ

  • G

    Gao, Yue

    harbin med univ

  • W

    Wang, Peng

    harbin med univ

  • Z

    Zhi, Hui

    harbin med univ

  • S

    Sun, Yue

    harbin med univ

  • Z

    Zhang, Yakun

    harbin med univ

  • G

    Gan, Jing

    harbin med univ

  • X

    Xiao, Yun (通讯)

    harbin med univ

  • N

    Ning, Shangwei (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417